Cancer drug trial halted over stability concerns; Philippines officials score fakes bust;

> Helix BioPharma's experimental cancer treatment was placed on clinical hold by the FDA, based on product stability concerns. Story

> The National Bureau of Investigation of the Philippines has made one arrest and seized about a half-million dollars' worth of fake medicines imported from India, Pakistan and Singapore. Article

Special Report:Top 10 Pharma CEO salaries of 2009. Report

> Hebei Aoxing API Pharmaceutical Company, a joint venture of Aoxing Pharma and Macfarlan Smith, has received a manufacturing licence from the China State Food and Drug Administration. Aoxing release

> A "tantalizing glimpse" of pharma company earnings is available from the spending breakdown of the U.K.'s Department of Health. Story

> India is considering whether to grant autonomous status to its three public-sector vaccine production units. Item

Special Report: Top 5 Game-Changing Drug Delivery Technologies. Report

> VR Laboratories, a start-up natural pharmaceutical company, is considering a site in Fort Myers, FL, for its headquarters. Article

> Hospira has named Frans Dubois to the new position of senior VP for Quality. Hospira release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.